Evidence map›Paper›PMID 29932149›Full record

ArticleInternational journal of molecular sciences2018

Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.

Emanuela Esposito, Michela Campolo, Giovanna Casili, Marika Lanza, Domenico Franco, Alessia Filippone, Alessio F Peritore, Salvatore Cuzzocrea

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Consumption of Cashew (Nutrients · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Health Potential ofAntioxidants (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Emanuela EspositoDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. eesposito@unime.it.
Michela CampoloDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. campolom@unime.it.
Giovanna CasiliDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. gcasili@unime.it.
Marika LanzaDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. mlanza@unime.it.
Domenico FrancoDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. dfranco@unime.it.
Alessia FilipponeDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. afilippone@unime.it.
Alessio F PeritoreDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. a.peritore2@campus.unimib.it.
Salvatore CuzzocreaDepartment of Chemical, Biological, Pharmacological and Environmental Sciences, University of Messina, 31-98166 Messina, Italy. salvator@unime.it.ORCID 0000-0001-6131-3690
University of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute infectious gastroenteritis (GE) and urinary tract infection (UTI) are common diseases and are normally perceived as mild and limiting illnesses. Xyloglucan is a natural plant polymer with protective barrier properties, also known as “mucosal protectors”, which is the main ingredient of medical devices developed for the management of different diseases, such as gastrointestinal diseases, urinary tract infections, or respiratory allergic diseases. The aim of this study was to evaluate the protective effect of xyloglucan in association with gelose (also called agar) in an experimental model of bacterial GE and UTI in rats. Two kinds of infection were induced by oral administration of

Indexed as

Host-Pathogen InteractionsAnimalsBacterial InfectionsDisease Models, AnimalEnterococcus hiraeGastroenteritisGlucansHumansIntestinesPolysaccharidesRats, Sprague-DawleySalmonella entericaTime FactorsUrinary Tract InfectionsXylansGlucansPolysaccharidesXylansxyloglucangastroenteritisgeloseurinary tract infectionxyloglucan

Identifiers

PMID29932149
PMCPMC6073600
OpenAlexW2809507431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.